The CAR T Cell Therapy Market is projected to grow at an annualized rate of 20% till 2035, according to a market research report by Roots Analysis

Presently, more than 250 companies are engaged in the development of more than 1,200 early and late-stage T-cell therapies, worldwide. Several promising leads are anticipated to be commercially launched over the coming decade, following which the market is projected to grow at a substantial pace. Over 6,800 patents related to CAR-T therapies, TCR therapies and TIL therapies have been recently filed / granted, demonstrating the continued innovation in this domain. In addition, close to 440 collaborations have been inked between industry / academic stakeholders to advance the development of various pipeline candidates. Moreover, to fund product development initiatives in this domain, capital investments worth USD 30 billion have been made by various private and public sector investors in the last few years.

Presently, more than 250 companies are engaged in the development of more than 1,200 early and late-stage T-cell therapies, worldwide. Several promising leads are anticipated to be commercially launched over the coming decade, following which the market is projected to grow at a substantial pace. Over 6,800 patents related to CAR-T therapies, TCR therapies and TIL therapies have been recently filed / granted, demonstrating the continued innovation in this domain. In addition, close to 440 collaborations have been inked between industry / academic stakeholders to advance the development of various pipeline candidates. Moreover, to fund product development initiatives in this domain, capital investments worth USD 30 billion have been made by various private and public sector investors in the last few years.

To order this 650+ page report, which features 350+ figures and 190+ tables, please visit https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html 

Key Market Insights

For more information, please visit

https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html 

The financial opportunity within the CAR-T cell therapies market has been analyzed across the following segments:

 

Target Indication(s)

 

Target Antigen

 

Key Geographical Regions 

 

The report features inputs from eminent industry stakeholders, according to whom, T-cell immunotherapies are expected to be the next big step in cancer immunotherapy. The report includes detailed transcripts of discussions held with the following experts:

The report includes brief profiles of key players (listed below); each profile features an overview of the company, details related to its financial information (if available), details about CAR-T-cell based product(s), such as information on type of therapy and current development status, information on technology portfolio (if available), recent developments related to CAR-T cell immunotherapies and manufacturing capabilities of the players. 

Key Questions Answered

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. CAR-T Cell Therapies: Market Landscape

5. Key Insights

6. Clinical Trial ANALYSIS

7. Key Opinion Leaders

8. CAR-T Cell Therapy Profiles

9. Partnerships and Collaborations

10. Funding and Investment Analysis

11. Patent Analysis

12. Case Study: Cell Therapy Manufacturing

13. Cost Price Analysis

14. Market Forecast and Opportunity Analysis

15. Promotional Analysis

16. Company Profiles

17. Concluding Remarks

18. Executive Insights

19. Appendix 1: Tabulated Data

20. Appendix 2: List of Companies and Organizations

For additional details, please visit https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html or email sales@rootsanalysis.com 

You may also be interested in the following titles:

1.  Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (6^th Edition), 2022- 2035

2.  Antiviral Drugs Market, 2022-2035

3.  mRNA Therapeutics and mRNA Vaccines Market (2^nd Edition), 2022-2035

Contact:

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
gaurav.chaudhary@rootsanalysis.com

Logo - https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/the-car-t-cell-therapy-market-is-projected-to-grow-at-an-annualized-rate-of-20-till-2035-according-to-a-market-research-report-by-roots-analysis-301932157.html